Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic Prostatitis

• Status: Unknown status
• Trial end date: 2010-01-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to determine whether tamsulosin and tolterodine are effective in the treatment of men with lower urinary tract symptoms and chronic prostatitis/chronic pelvic pain syndrome.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chongqing Medical University
• Collaborator: Fuling Central Hospital of Chongqing City
• Treatments: Tamsulosin; Tolterodine Tartrate

Criteria

Inclusion Criteria:

1. diagnosis of CP/CPPS based on the classification of US National Institutes of Health, aged 18-45 years

2. total score of at least 12 on the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)

3. urinary score of at least 4 on the CPSI

4. subjects who anticipate improving symptoms

Exclusion Criteria:

1. previous treatment with any other alpha-adrenergic receptor blocker and antimuscarinic agents for symptoms of CP/CPPS or for any other reason

2. those who had had previous urinary tract infection with the last year

3. those who had been treat or were taking medication that could affect lower urinary tract function

4. those who met the criteria for chronic bacterial prostatitis after lower urinary tract localization studies

5. those who had other significant medical problems